Position
Chief Business Officer
Company
METiS Pharmaceuticals
Description
METiS Pharmaceuticals announces the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22, 2025. In this role, Mr. Herbert will lead global business development, build key partnerships, and explore new opportunities to support METiS' growth and advance the commercialization of its drug delivery technologies.
Quick answer
METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer (CBO) (March 3, 2025).
- Who is the new Chief Business Officer at METiS Pharmaceuticals?
- METiS Pharmaceuticals named Mark Herbert Chief Business Officer, announced March 3, 2025.
- What did METiS Pharmaceuticals announce on March 3, 2025?
- METiS Pharmaceuticals announces the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22, 2025. In this role, Mr. Herbert will lead global business development, build key partnerships, and explore new opportunities to support METiS' growth and advance the commercialization of its drug delivery technologies.
- What does METiS Pharmaceuticals do?
- METiS Technologies is a pioneering TechBio company unlocking a healthier world through AI-driven nanotechnology.
- Which similar companies made leadership changes around the same time?
- Qureator (March 4, 2025), Alcresta Therapeutics (March 3, 2025), Imugene (March 4, 2025) and Neurenati Therapeutics (March 4, 2025) also announced leadership changes within 45 days of METiS Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Qureator Appoints Dr. Branka Mitrovic as Chief Scientific Officer (CSO) (March 4, 2025)
- Alcresta Therapeutics, Inc. names Jason Weiner as Chief Strategy and Business Development Officer and Chris Arnold as Chief Commercial Officer (March 3, 2025)
- Imugene Appoints Darren Keamy as Chief Financial Officer and Company Secretary (March 4, 2025)
- Neurenati Appoints Dr. Meriam Kabbaj as Chief Development Officer and Secures $1.7M Seed Financing (March 4, 2025)
- GenBio AI Appoints Dr. Ziv Bar-Joseph as Co-founder and Chief Scientific Officer (February 28, 2025)
- Sage Therapeutics appoints Michael Quirk, Ph.D. as Chief Medical Officer after Laura Gault steps down (March 7, 2025)
Who to call at METiS Pharmaceuticals, and when
A new leader at METiS Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day METiS Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at METiS Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at METiS Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment METiS Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
METiS Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.